Loading...
Docoh

China Botanic Pharmaceutical (CBPI)

Document and Entity Information

Document and Entity Information - shares3 Months Ended
Jan. 31, 2021Jul. 05, 2021
Cover [Abstract]
Document Type10-Q
Amendment Flagfalse
Document Period End DateJan. 31,
2021
Document Fiscal Period FocusQ1
Document Fiscal Year Focus2021
Current Fiscal Year End Date--10-31
Entity File Number001-34808
Entity Registrant NameChina Botanic Pharmaceutical
Entity Central Index Key0000926844
Entity Incorporation, State or Country CodeNV
Entity Current Reporting StatusNo
Entity Interactive Data CurrentNo
Entity Filer CategoryNon-accelerated Filer
Entity Small Businesstrue
Entity Emerging Growth Companyfalse
Entity Shell Companytrue
Entity Common Stock, Shares Outstanding37,239,536

BALANCE SHEET (Unaudited)

BALANCE SHEET (Unaudited) - USD ($)Jan. 31, 2021Oct. 31, 2020
ASSETS
Total Assets $ 0 $ 0
Current liabilities
Notes payable-related party5,500 0
Total current liabilities5,500 0
Total liabilities5,500 0
Commitments and contingencies0 0
Stockholders' Equity
Common stock, $0.001 par value 100,000,000, shares authorized, 37,239,536 shares issued and outstanding as of January 31, 2021 and October 31, 202037,240 37,240
Paid in Capital11,704,909 11,704,909
Accumulated deficit(11,747,649)(11,742,149)
Total Stockholders' (Deficit)(5,500)0
Total Liabilities and Stockholders' (Deficit) $ 0 $ 0

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical) - $ / sharesJan. 31, 2021Oct. 31, 2020
Statement of Financial Position [Abstract]
Common stock par value $ 0.001 $ 0.001
Common stock, shares authorized100,000,000 100,000,000
Common stock, shares issued37,239,536 37,239,536
Common stock, shares outstanding37,239,536 37,239,536

STATEMENT OF OPERATIONS (Unaudi

STATEMENT OF OPERATIONS (Unaudited) - USD ($)3 Months Ended
Jan. 31, 2021Jan. 31, 2020
Income Statement [Abstract]
Revenue $ 0 $ 0
Operating Expenses:
Administrative expenses5,500 0
Total operating expenses5,500 0
(Loss) from operations(5,500)0
Other expense
Other (expense) net0 0
Income (loss) before provision for income taxes(5,500)0
Tax Provision0 0
Net (Loss) $ (5,500) $ 0
Basic and diluted earnings(loss) per common share $ 0 $ 0
Weighted average number of shares outstanding37,239,536 37,239,536

STATEMENTS OF CHANGES IN STOCKH

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)Common StockAdditional Paid-In CapitalAccumulated DeficitTotal
Beginning balance, shares at Oct. 31, 201937,239,536
Beginning balance, value at Oct. 31, 2019 $ 37,240 $ 11,704,909 $ (11,742,149)
Net income (loss)
Ending balance, shares at Jan. 31, 202037,239,536
Ending balance, value at Jan. 31, 2020 $ 37,240 11,704,909 (11,742,149)
Beginning balance, shares at Oct. 31, 202037,239,536
Beginning balance, value at Oct. 31, 2020 $ 37,240 11,704,909 (11,742,149)0
Net income (loss)(5,500)(5,500)
Ending balance, shares at Jan. 31, 202137,239,536
Ending balance, value at Jan. 31, 2021 $ 37,240 $ 11,704,909 $ (11,747,649) $ (5,500)

STATEMENT OF CASH FLOWS (Unaudi

STATEMENT OF CASH FLOWS (Unaudited) - USD ($)3 Months Ended
Jan. 31, 2021Jan. 31, 2020
Cash Flows From Operating Activities:
Net income (loss) $ (5,500) $ 0
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Net cash (used for) operating activities(5,500)0
Cash Flows From Investing Activities:
Net cash provided by (used for) investing activities0 0
Cash Flows From Financing Activities:
Notes payable related party5,500 0
Net cash provided by financing activities5,500 0
Net Increase (Decrease) In Cash0 0
Cash At The Beginning Of The Period0 0
Cash At The End Of The Period0 0
Supplemental disclosure of cash flow information:
Cash paid for interest0 0
Cash paid for taxes $ 0 $ 0

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS3 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESSNOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS China Botanic Pharmaceutical Inc. (“the Company”,
CBPI, “we” “us”) was incorporated in the State of Nevada on August 18, 1988, originally under the corporate name
of Solutions, Incorporated. It was inactive until August 16, 1996, when it changed its corporate name to Suarro Communications,
Inc, and engaged in the business of providing internet based business services. This line of business was discontinued in 2006,
and CBPI became a non-operating public company. CBPI underwent a number of corporate name changes as follows:
June 1997 ComTech Consolidation Group, Inc
February 1999 E-Net Corporation
May 1999 E-Net Financial Corporation
January 2000 E-Net.Com Corporation
February 2000 E-Net Financial.Com Corporation
January 2002 Anza Capital, Inc (“Anza”)
June 2006 Renhuang Pharmaceuticals, Inc.
October 2010 China Botanic Pharmaceutical Inc. The Company has been inactive since September 2012. On February 4, 2021 as a result of a custodianship
in Clark County, Nevada, Case Number: A-20-827231-B Custodian Ventures LLC (“Custodian”) was appointed custodian of China
Botanic Pharmaceutical, Inc. (the “Company”). On the same date Custodian appointed David Lazar as the Company’s Chief
Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors. The Company’s year-end is October 31.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES3 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESNOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES Basis of Presentation The accompanying financial statements have been prepared
in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP Management’s Representation of Interim
Financial Statements The accompanying unaudited condensed consolidated
financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange
Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles
generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations,
and management believes that the disclosures are adequate to make the information presented not misleading. These condensed consolidated
financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial
position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative
of results for a full year. These condensed consolidated financial statements should be read in conjunction with the audited consolidated
financial statements and notes thereto at October 31, 2020 as presented in the Company’s Annual Report on Form 10-K. Going Concern The accompanying financial statements have been prepared
assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business for the twelve months following the date of these financial statements. As of January 31, 2021, the Company
had no cash and an accumulated deficit of $11,747,149. Because the Company does not expect that existing
operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s
ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative
sources of financing. Recently the Company being funded by David Lazar who extended interest-free demand loans to the Company. Historically,
the Company raised capital through private placements, to finance working capital needs and may attempt to raise capital through the sale
of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations
become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital,
and intends to continue this practice where feasible. Use of Estimates The preparation of financial statements in conformity
with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience,
known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available
as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying
amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates. Cash and cash equivalents The Company considers all highly liquid temporary
cash investments with an original maturity of three months or less to be cash equivalents. As of January 31, 2021 and October 31, 2020,
the Company had no cash on hand. Income taxes The Company accounts for income taxes under FASB ASC
740, ”Accounting for Income Taxes” ”Accounting
for Uncertainty in Income Taxes” The amount recognized is measured as the largest amount
of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company assesses the validity of its
conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change
its judgment regarding the likelihood of a tax position’s sustainability under audit. Net Loss per Share Net loss per common share is computed by dividing
net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260,
“Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income
by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are
determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. Recent Accounting Pronouncements There are no recent accounting pronouncements that
impact the Company’s operations.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS3 Months Ended
Jan. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONSNOTE 3 – RELATED PARTY TRANSACTIONS During the three months ended January 31, 2021 the
Custodian extended the Company an interest-free demand loan of $5,500 to help fund the Company’s expenses. As of January 31, 2021
and October 31, 2020, the balance of related party loans was $5,500 and $-0-, respectively.

EQUITY

EQUITY3 Months Ended
Jan. 31, 2021
Equity [Abstract]
EQUITYNOTE 4 – EQUITY Common Stock The Company has authorized 100,000,000 shares of $0.001
par value, common stock. As of January 31, 2021 and October 31, 2020 there were 37,239,536 shares of Common Stock issued and outstanding.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES3 Months Ended
Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIESNOTE 5 – COMMITMENTS AND CONTINGENCIES The Company did not have any contractual commitments
as of January 31, 2021 and October 31, 2020.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS3 Months Ended
Jan. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTSNOTE 6 – SUBSEQUENT EVENTS On February 4, 2021 as a result of a custodianship
in Clark County, Nevada, Case Number: A-20-827231-B Custodian Ventures LLC (“Custodian”) was appointed custodian of China
Botanic Pharmaceutical, Inc. (the “Company”). On the same date Custodian appointed David Lazar as the Company’s Chief
Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors. On July 2, 2021 the Company issued to Custodian Ventures
1,000,000 shares of newly designated A-1 Preferred Stock for service performed and as repayment of funds loaned to the Company. Each share
of A-1 Preferred Stock is convertible into 1,000 shares of common stock.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)3 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]
Basis of PresentationBasis of Presentation The accompanying financial statements have been prepared
in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP
Management's Representation of Interim Financial StatementsManagement’s Representation of Interim
Financial Statements The accompanying unaudited condensed consolidated
financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange
Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles
generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations,
and management believes that the disclosures are adequate to make the information presented not misleading. These condensed consolidated
financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial
position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative
of results for a full year. These condensed consolidated financial statements should be read in conjunction with the audited consolidated
financial statements and notes thereto at October 31, 2020 as presented in the Company’s Annual Report on Form 10-K.
Going ConcernGoing Concern The accompanying financial statements have been prepared
assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business for the twelve months following the date of these financial statements. As of January 31, 2021, the Company
had no cash and an accumulated deficit of $11,747,149. Because the Company does not expect that existing
operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s
ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative
sources of financing. Recently the Company being funded by David Lazar who extended interest-free demand loans to the Company. Historically,
the Company raised capital through private placements, to finance working capital needs and may attempt to raise capital through the sale
of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations
become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital,
and intends to continue this practice where feasible.
Use of EstimatesUse of Estimates The preparation of financial statements in conformity
with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience,
known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available
as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying
amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.
Cash and cash equivalentsCash and cash equivalents The Company considers all highly liquid temporary
cash investments with an original maturity of three months or less to be cash equivalents. As of January 31, 2021 and October 31, 2020,
the Company had no cash on hand.
Income taxesIncome taxes The Company accounts for income taxes under FASB ASC
740, ”Accounting for Income Taxes” ”Accounting
for Uncertainty in Income Taxes” The amount recognized is measured as the largest amount
of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company assesses the validity of its
conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change
its judgment regarding the likelihood of a tax position’s sustainability under audit.
Net Loss per ShareNet Loss per Share Net loss per common share is computed by dividing
net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260,
“Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income
by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are
determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.
Recent Accounting PronouncementsRecent Accounting Pronouncements There are no recent accounting pronouncements that
impact the Company’s operations.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)Jan. 31, 2021Oct. 31, 2020
Accounting Policies [Abstract]
Cash $ 0 $ 0
Accumulated deficit $ (11,747,649) $ (11,742,149)

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)3 Months Ended
Jan. 31, 2021Oct. 31, 2020
Related Party Transactions [Abstract]
Related party expenses $ 5,500
Notes payable-related party $ 5,500 $ 0

EQUITY (Details Narrative)

EQUITY (Details Narrative) - $ / sharesJan. 31, 2021Oct. 31, 2020
Equity [Abstract]
Common stock par value $ 0.001 $ 0.001
Common stock, shares authorized100,000,000 100,000,000
Common stock, shares issued37,239,536 37,239,536
Common stock, shares outstanding37,239,536 37,239,536

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)Jan. 31, 2021Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Contractual commitments $ 0 $ 0

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Custodian VenturesJul. 02, 2021shares
Preferred stock shares issued1,000,000
Preferred stock conversionEach share of A-1 Preferred Stock is convertible into 1,000 shares of common stock.